Loading...

ONCOTELIC THERAPEUTICS INC Other Situations 8-K Filing

NCTL

ONCOTELIC THERAPEUTICS INC

()

2025 8-K

Joint Development Agreement

Product Launch Announcement

Research Presentation

Financing Agreement

Stock Agreement Details

Milestone Amendment

Contract Amendment

Funding Agreement Completed

Debt Financing Agreement

Access to Research Tools

Investment Offering Details

Investor Presentation Update

Equity Offerings

Presentation Announcement

External Links:

On December 22, 2025, Oncotelic Therapeutics, Inc. announced open access to its PDAOAI platform for analyzing biomedical data and provided access to over 125,000 TGF-β publications through a research channel.

AI Assistant

ONCOTELIC THERAPEUTICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.